David Larsen
Stock Analyst at BTIG
(2.06)
# 1,117
Out of 4,667 analysts
73
Total ratings
33.33%
Success rate
-1.84%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $102.96 | +26.26% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $23.72 | +30.69% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $194.38 | +33.76% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $27.58 | +81.29% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $18.79 | +6.44% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $41.04 | +70.57% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $4.10 | +70.73% | 1 | Sep 17, 2024 | |
| PGNY Progyny | Downgrades: Neutral | n/a | $13.98 | - | 3 | Aug 7, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $210.63 | +13.94% | 1 | Jul 9, 2024 | |
| DCGO DocGo | Maintains: Buy | $11 → $7 | $4.10 | +70.73% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.42 | +158.30% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.20 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $41.82 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $49.90 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $11.31 | +297.88% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $7.36 | +185.33% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.67 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.56 | - | 2 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.79 | +68.35% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.00 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $6.57 | +1,345.97% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.84 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $120.34 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $621.14 | -74.24% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $8.24 | +749.51% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.73 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $56.83 | +49.57% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $11.89 | +93.44% | 1 | Nov 2, 2017 |
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $102.96
Upside: +26.26%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $23.72
Upside: +30.69%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $194.38
Upside: +33.76%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $27.58
Upside: +81.29%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $18.79
Upside: +6.44%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $41.04
Upside: +70.57%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.10
Upside: +70.73%
Progyny
Aug 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.98
Upside: -
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $210.63
Upside: +13.94%
DocGo
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $4.10
Upside: +70.73%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $5.42
Upside: +158.30%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.20
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $41.82
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $49.90
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $11.31
Upside: +297.88%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $7.36
Upside: +185.33%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.67
Upside: -
Apr 29, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.56
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $20.79
Upside: +68.35%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $9.00
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $6.57
Upside: +1,345.97%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.84
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $120.34
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $621.14
Upside: -74.24%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $8.24
Upside: +749.51%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.73
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $56.83
Upside: +49.57%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $11.89
Upside: +93.44%